Invention Grant
- Patent Title: Prophylactic or therapeutic agent for autism spectrum disorder
-
Application No.: US16068553Application Date: 2017-01-05
-
Publication No.: US10759768B2Publication Date: 2020-09-01
- Inventor: Keisuke Hirai , Takashi Ishikawa
- Applicant: TAKEDA PHARMACEUTICAL COMPANY LIMITED
- Applicant Address: JP Osaka
- Assignee: TAKEDA PHARMACEUTICAL COMPANY LIMITED
- Current Assignee: TAKEDA PHARMACEUTICAL COMPANY LIMITED
- Current Assignee Address: JP Osaka
- Agency: Michael Best & Friedrich LLP
- International Application: PCT/JP2017/000166 WO 20170105
- International Announcement: WO2017/119455 WO 20170713
- Main IPC: C07D263/52
- IPC: C07D263/52 ; C07D413/06 ; C07D277/60 ; A61P25/00 ; A61K31/428 ; A61K31/423
Abstract:
The present invention provides a prophylactic or therapeutic agent for an autism spectrum disorder containing compound (I) having melatonin receptor affinity. A compound represented by the formula: wherein each symbol is as described in the specification, or a salt thereof.
Public/Granted literature
- US20190040022A1 PROPHYLACTIC OR THERAPEUTIC AGENT FOR AUTISM SPECTRUM DISORDER Public/Granted day:2019-02-07
Information query
